Literature DB >> 10831842

Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain.

D Conklin1, S Holderman, T E Whitmore, M Maurer, A L Feldhaus.   

Abstract

The sequence of the ubiquitin protein is highly conserved between species and has facilitated the cloning of numerous ubiquitin-like proteins. In the present study, we report the cloning of the cDNA for human ubiquilin 3 (UBQLN3). The deduced amino acid sequence of UBQLN3 contains a UBQ domain (ubiquitin-like) in the amino terminus as well as two highly conserved domains found in several recently cloned ubiquitin-like proteins. One of these domains, termed the NP domain, is a highly conserved 93 amino acid region present in UBQLN3 and several ubiquitin-like proteins. The last conserved domain is the UBA domain (ubiquitin-associated) found in a variety of proteins of the ubiquination pathway. The human UBQLN3 gene was mapped to the 11p15 region of chromosome 11. Northern blot analysis of multiple human and mouse tissues demonstrated UBQLN3 mRNA expression specifically in testis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831842     DOI: 10.1016/s0378-1119(00)00122-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  28 in total

1.  Ubiquilin interacts and enhances the degradation of expanded-polyglutamine proteins.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Biochem Biophys Res Commun       Date:  2007-06-25       Impact factor: 3.575

2.  Dimerization of ubiquilin is dependent upon the central region of the protein: evidence that the monomer, but not the dimer, is involved in binding presenilins.

Authors:  Diana L Ford; Mervyn J Monteiro
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

3.  Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.

Authors:  Johannes Brettschneider; Vivianna M Van Deerlin; John L Robinson; Linda Kwong; Edward B Lee; Yousuf O Ali; Nathaniel Safren; Mervyn J Monteiro; Jon B Toledo; Lauren Elman; Leo McCluskey; David J Irwin; Murray Grossman; Laura Molina-Porcel; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-03-18       Impact factor: 17.088

4.  Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines.

Authors:  Joel A Cassel; Allen B Reitz
Journal:  Biochim Biophys Acta       Date:  2013-03-27

5.  Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways.

Authors:  D Seigneurin-Berny; A Verdel; S Curtet; C Lemercier; J Garin; S Rousseaux; S Khochbin
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  Pathogenic Ubqln2 gains toxic properties to induce neuron death.

Authors:  Qinxue Wu; Mujun Liu; Cao Huang; Xionghao Liu; Bo Huang; Niansheng Li; Hongxia Zhou; Xu-Gang Xia
Journal:  Acta Neuropathol       Date:  2014-11-12       Impact factor: 17.088

7.  Increased Ubqln2 expression causes neuron death in transgenic rats.

Authors:  Bo Huang; Qinxue Wu; Hongxia Zhou; Cao Huang; Xu-Gang Xia
Journal:  J Neurochem       Date:  2016-10       Impact factor: 5.372

Review 8.  Ubiquitin receptors and protein quality control.

Authors:  Xuejun Wang; Erin J M Terpstra
Journal:  J Mol Cell Cardiol       Date:  2012-10-06       Impact factor: 5.000

Review 9.  Structure, dynamics and functions of UBQLNs: at the crossroads of protein quality control machinery.

Authors:  Tongyin Zheng; Yiran Yang; Carlos A Castañeda
Journal:  Biochem J       Date:  2020-09-30       Impact factor: 3.857

10.  Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.

Authors:  Diana L Ford; Mervyn J Monteiro
Journal:  Biochemistry       Date:  2007-07-06       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.